Relationship of lipid alterations and impaired calcium homeostasis during myocardial ischemia

Advances in Lipobiology

Volumn 2, Issue C, 1997, Pages 1-28

  Buja, L Maximilian ^a   Miller, Joseph C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344417479     PISSN: 18745245     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5245(97)80003-1     Document Type: Article

References (69)

1. Barry W.H., and Bridge J.H.B. Intracellular calcium homeostasis in cardiac myocytes. Cire. Res. 87 (1993) 1806-1815
2. 2+]i in energy deprivation contracture. Circ. Res. 61 (1987) 726-734
3. In: Brachmann J., and Schömig A. (Eds). Adrenergic System and Ventricular Arrhythmias in Myocardial Infarction (1989), Springer-Verlag
4. Braunwald E. Mechanism of action of calcium channel blocking agents. N. Eng. J. Med. 307 (1982) 1618-1627
5. Buja L.M., Fattor R.A., Miller J.C., Chien K.R., and Willerson J.T. Effects of calcium loading and impaired energy production on metabolic and ultrastructural features of cell injury in cultured neonatal rat cardiac myocytes. Lab. Invest. 63 (1990) 320-331
6. Buja L.M., Eigenbrodt M., and Eigenbrodt E. Apotosis and necrosis: Basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 117 (1993) 1208-1214
7. Buja L.M., Hagler H.K., and Willerson J.T. Altered calcium homeostasis in the pathogenesis of myocardial ischemic and hypoxic injury. Cell Calcium 9 (1988) 205-217
8. Buja L.M. Lipid abnormalities in myocardial cell injury. Trends Cardiovascular Med. 1 (1991) 40-45
9. Burton K.P., Buja L.M., Sen A., Willerson J.T., and Chien K.R. Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Am. J. Pathol. 124 (1986) 238-245
10. Burton K.P., Morris A.C., Massey K.D., Buja L.M., and Hagler H.K. Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes. J. Molec. Cell Cardiol. 22 (1990) 1035-1047
11. Chien K.R., Sen A., Reynolds R., Chang A., Kim Y., Gunn M.D., Buja L.M., and Willerson J.T. Release of arachidonate from membrane phospholipids in cultured myocardial cells during ATP depletion: Correlation with progression of cell injury. J. Clin. Invest. 75 (1985) 1770-1780
12. Chien K.R., Reeves J.P., Buja L.M., Bonte F., Parkey R.W., and Willerson J.T. Phospholipid alterations in canine ischemie myocardium. Circ. Res. 48 (1981) 711-719
13. Chien K.R., Han A., Sen A., Buja L.M., and Willerson J.T. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Circ. Res. 54 (1984) 313-322
14. Corr P.B., Gross R.W., and Sobel B.E. Amphipathic metabolites and membrane dysfunction in ischemie myocardium. Circ. Res. 55 (1984) 135-154
15. 2+ cycling in cardiac myocytes by arachidonic acid. Circ. Res. 72 (1993) 376-386
16. Das D.K., Engelman R.M., Rousou JA., Breyer R.H., Otani H., and Lemeshow S. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am. J. Physiol. 25l (1986) H71-H79
17. Doeller J.E., and Wittenberg B.A. Intracellular calcium and high-energy phosphates in isolated cardiac myocytes. Am. J. Physiol. 259 (1990) H1851-H1859
18. Farber J.L., Kyle M.E., and Coleman J.B. Biology of disease: Mechanisms of cell injury by activated oxygen species. Lab. Invest. 62 (1990) 670-679
19. Ford D.A., and Gross R.W. Differential accumulation of diacyl and plasmalogenic diglycerides during myocardial ischemia. Ore. Res. 64 (1989) 173-177
20. Gross R.W. Myocardial phospholipases A2 and their membrane substrates. Trends Cardiovasc. Med. 2 (1992) 115-121
21. Gunn M.D., Sen A., Chang A., Willerson J.T., Buja L.M., and Chien KR. Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion. Am. J. Physiol. 249 (1985) H1188-H1194
22. Hagve T.A., Sprecher H., and Hohl CM. The effect of anoxia on lipid metabolism in isolated rat cardiac myocytes. J. Mol. Cardiol. 22 (1990) 1467-1475
23. Hazen S.L., and Gross R.W. Identification and characterization of human myocardial phospholipase A2 from transplant recipients suffering from end-stage ischemic heart disease. Circ. Res. 70 (1992) 486-495
24. Hazen S.L., and Gross R.W. Principles of membrane biochemistry and their applications to the pathophysiology of cardiovascular disease. In: Fozzard H.A., et al. (Ed). The Heart and Cardiovascular System. 2 ed. (1992), Raven Press, New York 839-860
25. Hazen S.L., Ford D.A., and Gross R.W. Activation of a membrane-associated phospholipase A2 during myocardial ischemia which is highly selective for plasmalogen substrate. J. Biol. Chem. 266 (1991) 5629-5633
26. 2. J. Biol. Chem. 266 (1991) 14526-14534
27. 2. J. Biol. Chem. 266 (1991) 7227-7232
28. Hostetler K.Y., and Jellison E.J. Role of phospholipases in myocardial ischemia: Effect of cardioprotective agents on the phospholipases A of heart cytosol and sarcoplasmic reticulum. vitro. Mol. Cell Biochem. 88 (1989) 77-82
29. Hseuh W., and Needleman P. Cardiac and renal lipases and prostaglandin biosynthesis. Lipids 14 (1979) 236-240
30. Janssen Y.M., van Houten B., Borm P.J.A., and Mossman B.T. Biology of disease: Cell and tissue responses to oxidative damage. Lab. Invest. 69 (1993) 261-274
31. Jones R.L., Miller J.C., Hagler H.K., Chien K.R., Willerson J.T., and Buja L.M. Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes. Am. J. Pathol. 135 (1989) 541
32. Katayama A., Buja L.M., and Miller J.C. Phospholipase inhibition prevents cell damage in metabolically-inhibited cardiac myocytes despite increased intracellular calcium. FASEB J. 6 (1992) A163
33. Katz A.M., and Messineo F.C. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ. Res. 48 (1981) 1-16
34. Koretsune Y., and Marban E. Mechanism of ischemic contracture in ferret hearts: relative roles of [Ca2+]j, elevation and ATP depletion. Am. J. Physiol. 258 (1990) H9-H16
35. Lee H.C., Monhabir R., Smith N., Franz MR., and Clusin W.T. Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo-1. Circulation 78 (1988) 1047-1059
36. Lefer A.M. Platelet activating factor (PAF) and its role in cardiac injury. In: Schrör K., and Sinzinger H. (Eds). Prostaglandins in Clinical Research: Cardiovascular System (1989), Alan R. Liss, New York 53-60
37. Lopaschuk G.D., Wambolt R.B., and Barr R.L. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J. Pharm. Exp. Therap. 264 (1993) 135-144
38. Massey K.D., and Burton K.P. Alpha-tocopherol attenuates myocardial membrane-related alterations resulting from ischemia and reperfusion. Am. J. Physiol. 256 (1989) H1192-H1199
39. Miller J.C., Buja L.M., Patel K.D., and Weiss R.H. Effects of phospholipase inhibition with bromoenol lactone in metabolically-inhibited, neonatal rat, cardiac myocytes. Circulation 88 Suppl. I (1993) 1-489
40. Miller J.C., and Weinhold P.A. Cholinephosphotransferase in rat lung: The m vitro synthesis of dipalmitoylphosphatidylcholine from dipalmitoylglycerol. J. Biol. Chem. 259 (1981) 12662-12665
41. Miyazaki Y., Gross R.W., Sobel BE., and Saffitz J.E. Selective turnover of sarcolemmal phospholipids with lethal cardiac myocyte injury. Am. J. Physiol. 259 (1990) C325-C331
42. Morris A.C., Hagler H.K., Willerson J.T., and Buja L.M. Relationship between calcium loading and impaired energy metabolism during Na+, K+ pump inhibition in cultured neonatal rat cardiac myocytes. J. Clin. Invest. 83 (1989) 1876-1877
43. Muntz K.H., Zhao M., and Miller J.C. Downregulation of myocardial β-adrenegic receptors: Receptor subtype selectivity. Circ. Res. 74 (1994) 369-375
44. Muntz K.H., Neyman S.L., and Miller J.C. Alterations in alpha,-adrenergic receptor-mediated phosphatidylinositol turnover in hypoxic myocytes. J. Mol. Cell Biol. 25 (1993) 1187-1202
45. Opie L.H. The mechanism of myocyte death in ischemia. Eur. Heart J. 14G (1993) 31-33
46. Otani H., Renuka M., Jones R.M., and Das D.K. Mechanism of membrane phospholipid degradation in ischemic-reperfused rat hearts. Am. J. Physiol. 257 (1989) H252-H258
47. Patel T., Gores G.J., and Kaufmann S.H. The role of proteases during apoptosis. FASEB J. 10 (1996) 587-597
48. Pauly D.F., Yoon S.B., and McMillin J.B. Carnitine-acylcarnitine translocase in ischemia: Evidence for sulfhydryl modification. Am. J. Physiol. 253 (1987) H1152-H1565
49. Philipson K.D., and Ward R. Effects of fatty acids on Na+-Ca2+ exchange and Ca2+ permeability of cardiac sarcolemmal vesicles. J. Biol. Chem. 260 (1985) 9666-9671
50. Reimer K.A., and Jennings R.B. Myocardial ischemia, hypoxia, and infarction. In: Fozzard H.A., Haber E., Jennings R.B., Katz A.M., and Morgan H.E. (Eds). The Heart and Cardiovascular System (1986) 1133-1201
51. Revtyak G.E., Buja L.M., Chien K.R., and Campbell W.B. Reduced arachidonate metabolism in ATP-depleted myocardial cell occurs early in cell injury. Am. J. Physiol. 259 (1990) H582-H591
52. Saddik M., Gamble J., Witters LA., and Lopaschuk G.D. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J. Biol. Chem. 268 (1993) 25836-25845
53. Sen A., Miller J.C., Reynolds R., Willerson J.T., Buja L.M., and Chien K.R. Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion. J. Clin. Invest. 82 (1988) 1333
54. Shaikh N.A., and Downar E. Time course of changes in porcine myocardial phospholipid levels during ischemia. Circ. Res. 49 (1981) 316-325
55. Shaikh N.A., and Downar E. Effects of chronic amiodarone treatment on cat myocardial phospholipid content and on in vitro phospholipid catabolism. Mol. Cell Biochem. 78 (1987) 17-25
56. Shaikh N.A. Effect of amiodarone therapy on the time course of myocardial phospholipid hydrolysis during in vitro total ischaemia in cat hearts. J. Molec. Cell. Cardiol. 24 (1992) 507-521
57. Siesjö B.K., and Katsura K. ischemic brain damage: Focus on lipids and lipid messengers. In: Bazan N.G., Muphy M.G., and Toffano G. (Eds). Neurobiology of Essential Fatty Acids (1992), Plenum Press, New York 41-56
58. Singer S.S., and Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 175 (1972) 720-731
59. Spector A.A., and Yorek M.A. Membrane lipid composition and cellular function. J. Lipid Res. 26 (1985) 1015-1035
60. Steenbergen G., Murphy E., Watts J.A., and London R.E. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused tat heart. Circ. Res. 66 (1990) 135-146
61. Thandroyen F.T., Bellotto D., Katayama A., Hagler H.K., Willerson J.T., and Buja L.M. Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes. Circ. Res. 71 (1992) 106-119
62. Thandroyen F.T., Morris A.C., Hagler H.K., Ziman B., Pai L., Willerson J.T., and Buja L.M. Intracelluiar calcium transients and arrhythmias in isolated cells. Circ. Res. 69 (1991) 810-819
63. van Bilsen M., van der Vusse G.J., Willemsen P.H.M., Coumans W.A., Roemen T.H.M., and Reneman R.S. Lipid alterations in isolated, working rat hearts during ischemia and reperfusion: Its relation to myocardial ischemia. Circ. Res. 64 (1989) 304-314
64. van der Vusse G.J., Prinzen F.W., van Bilsen M., Engels W., and Reneman R.S. Accumulation of lipids and lipid-intermediates in the heart during ischemia. Basic Res. Cardiol. 82 (1987) 157-167
65. Van Winkle W.B., Snuggs M., and Buja L.M. Hypoxia-induced alterations in cytoskeleton coincide with collagenase expression in cultured neonatal rat cardiomyoeytes. J. Molec. Cell. Cardiol. 27 (1995) 2532-2542
66. Wang D., McMillin J.B., Bick R., and Buja L.M. Response of the neonatal rat cardiomyocyte in culture to energy depletion: Effects of cytokines, nitric oxide, and heat shock proteins. Lab. Invest. 75 (1996) 809-818
67. Weinberg J.M. The cell biology of ischemie renal injury. Kidney Int. 39 (1991) 476-500
68. 2 in canine myocardium. J. Biol. Chem. 260 (1985) 7295-7303
69. Ziegler D.M. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Ann. Rev. Biochem. 54 (1985) 305-329